NCT04334109

Brief Summary

The investigators conducted a comparative effectiveness randomized controlled trial comparing a family model diabetes self-management education and support intervention (Family-DSMES) and a standard model DSMES intervention (Standard-DSMES). The trial included 550 persons with type 2 diabetes mellitus (PWD) and 550 of their family members/support persons. PWD were randomly assigned to either the Family-DSMES arm or the Standard-DSMES arm. In the Family-DSMES arm, the family members/support persons of the PWD took part in the educational sessions. In the Standard-DSMES arm, the family members/support persons did not participate in educational sessions or goal setting. Both interventions were delivered in a group setting via telehealth. Baseline, immediate post-intervention (12 weeks) and 6 months post-intervention data were collected from PWD and family members/support persons in both study arms. In both study arms, we obtained a medical records release to abstract the primary outcome at 12 months post-intervention and 18 months post-intervention for PWD. The primary outcome was change in Hemoglobin A1c between baseline and immediate post-intervention among PWD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,100

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 6, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

January 4, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 17, 2024

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

June 22, 2026

Completed
Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

2.4 years

First QC Date

March 26, 2020

Results QC Date

March 27, 2026

Last Update Submit

June 18, 2026

Conditions

Keywords

diabetes self-management education and supporttype 2 diabetescomparative effectivenessrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Hemoglobin A1c (HbA1c)

    A Siemens DCA Vantage analyzer was utilized to collect HbA1c from participants via finger stick blood collection (except for 12 months post-intervention and 18 months post-intervention, which was collected through medical record abstractions).

    Baseline, immediate post-intervention, 6 months post-intervention, 12 months post-intervention, 18 months post-intervention

Secondary Outcomes (25)

  • Body Mass Index (BMI)

    Baseline, immediate post-intervention, 6 months post-intervention

  • Systolic Blood Pressure

    Baseline, immediate post-intervention, 6 months post-intervention

  • Diastolic Blood Pressure

    Baseline, immediate post-intervention, 6 months post-intervention

  • Glucose

    Baseline, immediate post-intervention

  • Total Cholesterol

    Baseline, immediate post-intervention

  • +20 more secondary outcomes

Study Arms (2)

Family-DSMES

EXPERIMENTAL

The Family-DSMES intervention uses family motivational interviewing techniques and family goal setting, and focuses on understanding supportive and non-supportive family behaviors and creating family level behavioral change. Family-DSMES is delivered in group sessions via telehealth by a certified diabetes care and education specialist (CDCES) to patients and their family members. The intervention includes 10 hours of education delivered over 10 weeks in one-hour sessions. Family members in the Family-DSMES arm take part in educational sessions and data collection.

Behavioral: Family-DSMES

Standard-DSMES

ACTIVE COMPARATOR

The Standard-DSMES intervention uses individual motivational interviewing techniques and individual goal setting, and focuses on creating individual level behavioral change. Standard-DSMES is delivered in group sessions via telehealth by a certified diabetes care and education specialist (CDCES) to patients only. The intervention includes 10 hours of education delivered over 10 weeks in one-hour sessions. Family members take part in data collection but do not take part in educational sessions.

Behavioral: Standard-DSMES

Interventions

Family-DSMESBEHAVIORAL

Family Diabetes Self-Management Education and Support demonstrates the effectiveness of family-centered models of DSMES that explicitly address diabetes self-management within a family context by educating both patients and family members and focusing on family motivational interviewing, family goal setting, understanding supportive and non-supportive behaviors, and family behavioral changes.

Family-DSMES
Standard-DSMESBEHAVIORAL

Diabetes Self-Management Education and Support demonstrates the effectiveness of individual model DSMES that explicitly address diabetes self-management within an individual context by educating individual patients on individual motivational interviewing, individual goal setting, and individual behavioral changes.

Standard-DSMES

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults ≥18 years of age
  • have HbA1c ≥ 7.0%
  • speak English
  • have a family member/support person willing to take part in the study

You may not qualify if:

  • have received formal DSMES in the past three years
  • have a condition that makes it unlikely for them to be able to follow the study protocol, such as a terminal illness
  • have plans to move out of the area within 18 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences Northwest

Fayetteville, Arkansas, 72703, United States

Location

Related Publications (2)

  • Mayberry LS, Felix HC, Hudson J, Curran GM, Long CR, Selig JP, Carleton A, Baig A, Warshaw H, Peyrot M, McElfish PA. Effectiveness-implementation trial comparing a family model of diabetes self-management education and support with a standard model. Contemp Clin Trials. 2022 Oct;121:106921. doi: 10.1016/j.cct.2022.106921. Epub 2022 Sep 9.

    PMID: 36096282BACKGROUND
  • Andersen JA, McElfish PA, Selig JP, Li J, Rowland B, Hudson J, Kraleti S, Henske J, Mayberry LS. Comparative effectiveness of telehealth-delivered family and standard models of diabetes self-management education and support for persons with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2026 Feb;232:113063. doi: 10.1016/j.diabres.2025.113063. Epub 2025 Dec 20.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Limitations and Caveats

The study was implemented via telehealth, and results may have differed if offered via in-person group sessions. While participants were diverse (race/ethnicity, rural/urban), all participants were from Arkansas, which reduces generalizability. Participants had to have a family member/support person to participate with them, which precluded some potential participants. Survey metrics were assessed only at baseline and immediate post-intervention, so durability of findings cannot be assessed.

Results Point of Contact

Title
Dr. Pearl McElfish
Organization
University of Arkansas for Medical Sciences

Study Officials

  • Pearl McElfish, PhD

    UAMS

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2020

First Posted

April 6, 2020

Study Start

January 4, 2021

Primary Completion

May 17, 2023

Study Completion

September 17, 2024

Last Updated

June 22, 2026

Results First Posted

June 22, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations